Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 7.99%34.2B | -3.87%31.67B | -6.64%8.32B | -4.60%8.24B | -3.88%7.8B | 0.40%7.31B | 7.66%32.94B | 5.26%8.91B | 8.53%8.64B | 10.62%8.11B |
| Cost of revenue | 7.12%26.89B | -4.52%25.1B | -7.50%6.64B | -5.58%6.45B | -5.68%6.15B | 1.74%5.86B | 8.65%26.29B | 7.41%7.18B | 8.96%6.83B | 11.69%6.52B |
| Gross profit | 11.26%7.31B | -1.29%6.57B | -3.11%1.68B | -0.94%1.79B | 3.51%1.65B | -4.67%1.45B | 3.94%6.66B | -2.86%1.73B | 7.05%1.81B | 6.40%1.6B |
| Operating expense | 3.24%5.93B | 1.27%5.74B | -1.39%1.49B | 2.61%1.46B | 4.37%1.41B | -0.21%1.39B | 1.50%5.67B | 4.01%1.51B | 3.35%1.42B | -1.03%1.35B |
| Staff costs | 3.26%3.62B | 1.60%3.5B | ---- | ---- | ---- | ---- | -1.35%3.45B | ---- | ---- | ---- |
| Selling and administrative expenses | 8.27%982M | 3.30%907M | ---- | ---- | ---- | ---- | 4.03%878M | ---- | ---- | ---- |
| -General and administrative expense | 8.27%982M | 3.30%907M | ---- | ---- | ---- | ---- | 4.03%878M | ---- | ---- | ---- |
| Depreciation and amortization | 6.22%205M | 4.32%193M | ---- | ---- | ---- | ---- | 1.65%185M | ---- | ---- | ---- |
| -Depreciation | 6.22%205M | 4.32%193M | ---- | ---- | ---- | ---- | 1.65%185M | ---- | ---- | ---- |
| Other operating expenses | -1.31%1.13B | -1.72%1.14B | ---- | ---- | ---- | ---- | 8.80%1.16B | ---- | ---- | ---- |
| Operating profit | 67.07%1.38B | -16.06%826M | -14.47%195M | -13.92%334M | -1.22%243M | -55.74%54M | 20.59%984M | -32.34%228M | 23.17%388M | 80.88%246M |
| Net non-operating interest income (expenses) | 39.13%-14M | 4.17%-23M | -50.00%-3M | 0.00%-7M | 12.50%-7M | 14.29%-6M | 11.11%-24M | 50.00%-2M | 12.50%-7M | 0.00%-8M |
| Non-operating interest income | 150.00%10M | 0.00%4M | ---- | ---- | ---- | ---- | -20.00%4M | ---- | ---- | ---- |
| Non-operating interest expense | -11.11%24M | -3.57%27M | 16.67%7M | 0.00%7M | -12.50%7M | -14.29%6M | -12.50%28M | -33.33%6M | -12.50%7M | 0.00%8M |
| Net investment income | 1.01%100M | 1.02%99M | 0 | 8.57%38M | -25.93%20M | -21.15%41M | 28.95%98M | -206.67%-16M | 25.00%35M | 125.00%27M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 2,250.00%47M | 200.00%2M | -200.00%-6M | 2M | 0 | 6M | -105.00%-2M | -2M | 0 | 0 |
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -277.78%-208M | 72.06%117M | -4,400.00%-90M | 66.67%-1M | 185.92%203M | 150.00%5M | 4.62%68M | -108.33%-2M | 97.06%-3M | 373.33%71M |
| Less:Restructuring and mergern&acquisition | ---- | --0 | --0 | ---- | ---- | ---- | -96.97%3M | --0 | ---- | ---- |
| Less:Other special charges | 204.41%213M | -195.65%-204M | -166.67%-2M | ---1M | ---- | ---- | 75.62%-69M | 102.80%3M | --0 | ---- |
| Less:Write off | -105.75%-5M | 4,450.00%87M | 9,300.00%92M | --2M | -300.00%-2M | -150.00%-5M | -101.68%-2M | -101.20%-1M | --0 | --1M |
| Other non-operating income (expenses) | -48.65%19M | 362.50%37M | 14M | -9.09%10M | 350.00%5M | 900.00%8M | -84.31%8M | 0 | 257.14%11M | -111.11%-2M |
| Income before tax | 25.26%1.32B | -6.48%1.05B | -47.76%105M | -11.14%375M | 39.22%465M | -36.09%108M | 10.39%1.13B | -46.26%201M | 87.56%422M | 56.81%334M |
| Income tax | -66.84%65M | -30.99%196M | -457.14%-100M | -12.07%102M | 58.44%122M | 14.29%72M | 10.08%284M | 64.71%28M | 6.42%116M | 30.51%77M |
| Net income | 46.21%1.25B | 1.78%857M | 19.08%206M | -10.78%273M | 32.95%343M | -66.67%35M | 10.64%842M | -51.40%173M | 161.54%306M | 68.63%258M |
| Net income continuous operations | 46.32%1.25B | 1.78%857M | 18.50%205M | -10.78%273M | 33.46%343M | -66.04%36M | 10.50%842M | -51.54%173M | 163.79%306M | 66.88%257M |
| Noncontrolling interests | -16.67%5M | 500.00%6M | 0 | 0 | 4M | 100.00%2M | -66.67%1M | 0 | 0 | 0 |
| Net income attributable to the company | 46.65%1.25B | 1.31%851M | 19.77%206M | -10.78%273M | 31.40%339M | -68.27%33M | 10.82%840M | -51.69%172M | 163.79%306M | 69.74%258M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 46.65%1.25B | 1.31%851M | 19.77%206M | -10.78%273M | 31.40%339M | -68.27%33M | 10.82%840M | -51.69%172M | 163.79%306M | 69.74%258M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 45.76%150.13 | 0.67%103 | 18.80%24.8526 | -11.31%33.03 | 31.11%41.13 | -68.47%4.03 | 10.32%102.31 | -51.87%20.92 | 163.74%37.24 | 68.11%31.37 |
| Diluted earnings per share | 45.76%150.13 | 0.67%103 | 18.87%24.8526 | -11.46%32.9349 | 31.11%41.13 | -68.47%4.03 | 10.32%102.31 | -51.90%20.9076 | 163.43%37.1961 | 68.22%31.37 |
| Dividend per share | 68.18%37 | 10.00%22 | 16.67%14 | 0 | 0.00%8 | 0 | 11.11%20 | 20.00%12 | 0 | 0.00%8 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |